sorafenib generic — Cigna
Differentiated Thyroid Carcinoma
Initial criteria
- Patient age ≥ 18 years
- Patient meets ONE of the following (i or ii):
- i. Patient has papillary or follicular thyroid carcinoma AND disease is refractory to radioactive iodine therapy
- ii. Patient has oncocytic (formerly Hürthle cell) carcinoma
Approval duration
1 year